AcrySof® IQ PanOptix® Toric Trifocal IOL TFNT60 (REF TFNT60U285)Recalls & reported problems
Alcon Laboratories, Inc. · AcrySof® IQ PanOptix® Toric Trifocal intraocular lenses (IOLs) are ultraviolet absorbing and blue light filtering foldable multifocal IOLs · Class 3 · Implant
All models of AcrySof IQ PanOptix Toric Trifocal IOL (165)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652417280), received between Mar 24, 2021 and Mar 24, 2021 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Blurred Vision1
- Corneal Scar1
- Scar Tissue1
- Vertigo1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMar 24, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ADDITIONAL INFORMATION HAS BEEN RECEIVED STATING I WAS TOLD I HAVE SCARRING BEHIND THIS LENS, AND HAVE ATTACHED AN IR PHOTO OF THE SURFACE OF MY EYE AND HOW IT REACTED TO THE IMPLANT, REQUIRING TWO MORE SURFACE/REMOVAL SURGERIES BY DOCTOR PEABODY. THE SURFACE WAS CLEARED UP BY THE TWO ADDITIONAL SURFACE SURGERIES AND HAS RESOLVED THAT ISSUE. WAS TOLD THE SCAR BEHIND THE IMPLANT WAS TOO RISKY TO REMOVE, THAT IT COULD JUST SCAR AGAIN, AND THAT IT WAS NOT POSSIBLE TO SEE IF THE LENS WAS PLACED IMPROPERLY, OR IF IT HAS SHIFTED, DUE TO SCARRING AROUND THE LENS. TOLD REMOVING OR REPLACING LENS, NOT AN OPTION, AS RISKS TOTAL BLINDNESS. I AM ON THE 5TH PAIR OF GLASSES TO CORRECT IMBALANCE BETWEEN THE EYES NOW, HAVE HAD SEVERE VERTIGO, UNABLE TO READ, AND NEED R EYE CATARACT REMOVED AS WELL. LATEST SCRIPT IS ALLOWING SOME READING, CORRECTED MOST OF HORIZON LINE ISSUE, AND STILL HAVE SOME VERTIGO. YOU CAN IMAGINE I AM TOTALLY RELUCTANT TO HAVE THE R EYE CATARACT REMOVAL WITH THIS PREVIOUS ORDEAL. I AM SUBMITTING THIS AND WILLING TO HELP YOU SORT THIS OUT, SO NO ONE ELSE HAS TO GO THROUGH THIS. THANK YOU FOR THIS EFFORT TO FIND OUT WHAT WENT WRONG. YOU SHOULD ALSO KNOW I HAVE MULTIPLE AUTO IM
Patient problems: Blurred Vision; Corneal Scar; Scar Tissue; Vertigo
MAUDE report 11560521 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page